Cargando…

Rubella seroprevalence among pregnant women in the region of Rabat, Morocco: a cross-sectional study

OBJECTIVES: The aim of the present research is to update data on the seroprevalence of rubella and to identify the associated risk factors among pregnant women in the Rabat region of Morocco in order to take immediate action to monitor the virus. DESIGN: A cross-sectional study. SETTING: The study w...

Descripción completa

Detalles Bibliográficos
Autores principales: Lamrani Alaoui, Hafsa, Seffar, Myriam, Kassouati, Jalal, Zouaki, Amal, Kabbaj, Hakima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10254781/
https://www.ncbi.nlm.nih.gov/pubmed/37263690
http://dx.doi.org/10.1136/bmjopen-2022-067842
_version_ 1785056723506036736
author Lamrani Alaoui, Hafsa
Seffar, Myriam
Kassouati, Jalal
Zouaki, Amal
Kabbaj, Hakima
author_facet Lamrani Alaoui, Hafsa
Seffar, Myriam
Kassouati, Jalal
Zouaki, Amal
Kabbaj, Hakima
author_sort Lamrani Alaoui, Hafsa
collection PubMed
description OBJECTIVES: The aim of the present research is to update data on the seroprevalence of rubella and to identify the associated risk factors among pregnant women in the Rabat region of Morocco in order to take immediate action to monitor the virus. DESIGN: A cross-sectional study. SETTING: The study was conducted at Ibn Sina University Hospital and at referral healthcare centres in the region of Rabat. PARTICIPANTS: A total of 502 pregnant women (mean age 29.7±6.3 years, range 17–44 years) attending the maternity department during 8 months were selected for serological testing. OUTCOME MEASURES: A structured questionnaire was used to obtain sociodemographic, reproductive and clinical characteristics after obtaining written informed consent. Venous blood samples were collected to determine rubella-specific IgG antibodies using an automated chemiluminescent microparticle immunoassay (ARCHITECT i1000SR and i2000SR, Abbott Diagnostics). RESULTS: Antirubella IgG antibodies (≥10 IU/mL) were found in 408 (85.9%) pregnant women examined. The rate of susceptibility to rubella virus infection among pregnant women was found to be 14.1%. These protective rates were found to differ significantly between uneducated pregnant women (80.9%) and those with university-level education (95.5%) (p=0.02). Pregnant women in the 17–24, 25–34 and 35–44 years age groups accounted for 92.5%, 85.2% and 82.8%, respectively (p=0.015). Also, IgG seropositivity status was found to differ significantly between multiparous (83.3%) and primiparous (92.5%) pregnant women (p=0.01). None of the other characteristics was significantly associated with rubella infections. CONCLUSION: Vaccination programmes need to be updated to ensure that campaigns reach their specified goals. Thus, implementing an effective, large-scale screening programme for congenital rubella infection in different regions of Morocco is highly recommended. On the other hand, seronegative pregnant women should be given special preventive care and health education about rubella transmission and congenital rubella syndrome sequelae.
format Online
Article
Text
id pubmed-10254781
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-102547812023-06-10 Rubella seroprevalence among pregnant women in the region of Rabat, Morocco: a cross-sectional study Lamrani Alaoui, Hafsa Seffar, Myriam Kassouati, Jalal Zouaki, Amal Kabbaj, Hakima BMJ Open Epidemiology OBJECTIVES: The aim of the present research is to update data on the seroprevalence of rubella and to identify the associated risk factors among pregnant women in the Rabat region of Morocco in order to take immediate action to monitor the virus. DESIGN: A cross-sectional study. SETTING: The study was conducted at Ibn Sina University Hospital and at referral healthcare centres in the region of Rabat. PARTICIPANTS: A total of 502 pregnant women (mean age 29.7±6.3 years, range 17–44 years) attending the maternity department during 8 months were selected for serological testing. OUTCOME MEASURES: A structured questionnaire was used to obtain sociodemographic, reproductive and clinical characteristics after obtaining written informed consent. Venous blood samples were collected to determine rubella-specific IgG antibodies using an automated chemiluminescent microparticle immunoassay (ARCHITECT i1000SR and i2000SR, Abbott Diagnostics). RESULTS: Antirubella IgG antibodies (≥10 IU/mL) were found in 408 (85.9%) pregnant women examined. The rate of susceptibility to rubella virus infection among pregnant women was found to be 14.1%. These protective rates were found to differ significantly between uneducated pregnant women (80.9%) and those with university-level education (95.5%) (p=0.02). Pregnant women in the 17–24, 25–34 and 35–44 years age groups accounted for 92.5%, 85.2% and 82.8%, respectively (p=0.015). Also, IgG seropositivity status was found to differ significantly between multiparous (83.3%) and primiparous (92.5%) pregnant women (p=0.01). None of the other characteristics was significantly associated with rubella infections. CONCLUSION: Vaccination programmes need to be updated to ensure that campaigns reach their specified goals. Thus, implementing an effective, large-scale screening programme for congenital rubella infection in different regions of Morocco is highly recommended. On the other hand, seronegative pregnant women should be given special preventive care and health education about rubella transmission and congenital rubella syndrome sequelae. BMJ Publishing Group 2023-06-01 /pmc/articles/PMC10254781/ /pubmed/37263690 http://dx.doi.org/10.1136/bmjopen-2022-067842 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Epidemiology
Lamrani Alaoui, Hafsa
Seffar, Myriam
Kassouati, Jalal
Zouaki, Amal
Kabbaj, Hakima
Rubella seroprevalence among pregnant women in the region of Rabat, Morocco: a cross-sectional study
title Rubella seroprevalence among pregnant women in the region of Rabat, Morocco: a cross-sectional study
title_full Rubella seroprevalence among pregnant women in the region of Rabat, Morocco: a cross-sectional study
title_fullStr Rubella seroprevalence among pregnant women in the region of Rabat, Morocco: a cross-sectional study
title_full_unstemmed Rubella seroprevalence among pregnant women in the region of Rabat, Morocco: a cross-sectional study
title_short Rubella seroprevalence among pregnant women in the region of Rabat, Morocco: a cross-sectional study
title_sort rubella seroprevalence among pregnant women in the region of rabat, morocco: a cross-sectional study
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10254781/
https://www.ncbi.nlm.nih.gov/pubmed/37263690
http://dx.doi.org/10.1136/bmjopen-2022-067842
work_keys_str_mv AT lamranialaouihafsa rubellaseroprevalenceamongpregnantwomenintheregionofrabatmoroccoacrosssectionalstudy
AT seffarmyriam rubellaseroprevalenceamongpregnantwomenintheregionofrabatmoroccoacrosssectionalstudy
AT kassouatijalal rubellaseroprevalenceamongpregnantwomenintheregionofrabatmoroccoacrosssectionalstudy
AT zouakiamal rubellaseroprevalenceamongpregnantwomenintheregionofrabatmoroccoacrosssectionalstudy
AT kabbajhakima rubellaseroprevalenceamongpregnantwomenintheregionofrabatmoroccoacrosssectionalstudy